{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T23:25:10Z","timestamp":1772061910707,"version":"3.50.1"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T00:00:00Z","timestamp":1638230400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2020M683094"],"award-info":[{"award-number":["2020M683094"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972263"],"award-info":[{"award-number":["81972263"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072714"],"award-info":[{"award-number":["82072714"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p><jats:bold>Background and Aims:<\/jats:bold> Cholecystectomy is the \u201cgold standard\u201d for treating diseases of the gallbladder. In addition, non-alcoholic fatty liver disease (NAFLD), liver fibrosis or cirrhosis, are major causes of morbidity and mortality across the world. However, the association between cholecystectomy and these diseases is still unclear. We assessed the association among US adults and examined the possible risk factors.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> This cross-sectional study used data from 2017 to 2018 National Health and Nutrition Examination Survey, a population-based nationally representative sample of US. Liver fibrosis and cirrhosis were defined by median stiffness, which was assessed by transient elastography. Furthermore, patients who had undergone cholecystectomy were identified based on the questionnaire. In addition, Propensity Score Matching (PSM, 1:1) was performed based on gender, age, body mass index (BMI) and diabetes.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Of the 4,497 included participants, cholecystectomy was associated with 60.0% higher risk of liver fibrosis (OR:1.600;95% CI:1.278\u20132.002), and 73.3% higher risk of liver cirrhosis (OR:1.733, 95% CI:1.076\u20132.792). After PSM based on age, gender, BMI group and history of diabetes, cholecystectomy was associated with 139.3% higher risk of liver fibrosis (OR: 2.393;95% CI: 1.738\u20133.297), and 228.7% higher risk of liver cirrhosis (OR: 3.287, 95% CI: 1.496\u20137.218).<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> The present study showed that cholecystectomy is positively associated with liver fibrosis and cirrhosis in US adults. The discovery of these risk factors therefore provides new insights on the prevention of NAFLD, liver fibrosis, and cirrhosis.<\/jats:p>","DOI":"10.3389\/fmed.2021.787777","type":"journal-article","created":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T16:55:45Z","timestamp":1638377745000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Association of Cholecystectomy With Liver Fibrosis and Cirrhosis Among Adults in the USA: A Population-Based Propensity Score-Matched Study"],"prefix":"10.3389","volume":"8","author":[{"given":"Zhi-Qin","family":"Xie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Xia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Liang","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Wu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing-Bin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Zhen","family":"Shang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Jin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.jhep.2021.05.003","article-title":"The Chinese Society of Hepatology position statement on the redefinition of fatty liver disease","volume":"75","author":"Nan","year":"2021","journal-title":"J Hepatol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"k2817","DOI":"10.1136\/bmj.k2817","article-title":"Mortality due to cirrhosis and liver cancer in the United States, 1999\u20132016: observational study","volume":"362","author":"Tapper","year":"2018","journal-title":"BMJ."},{"key":"B3","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","article-title":"Burden of liver diseases in the world","volume":"70","author":"Asrani","year":"2019","journal-title":"J Hepatol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","article-title":"Molecular and cellular mechanisms of liver fibrosis and its regression","volume":"18","author":"Kisseleva","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/s41575-019-0145-7","article-title":"From NASH to HCC: current concepts and future challenges","volume":"16","author":"Anstee","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.jhep.2017.07.027","article-title":"Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD","volume":"67","author":"Hagstrom","year":"2017","journal-title":"J Hepatol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"16024","DOI":"10.1038\/nrdp.2016.24","article-title":"Gallstones","volume":"2","author":"Lammert","year":"2016","journal-title":"Nat Rev Dis Primers."},{"key":"B8","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.surg.2021.04.004","article-title":"Comparative outcomes of needlescopic, single-incision laparoscopic, standard laparoscopic, mini-laparotomy, and open cholecystectomy: A systematic review and network meta-analysis of 96 randomized controlled trials with 11,083 patients","volume":"170","author":"Zhao","year":"2021","journal-title":"Surgery."},{"key":"B9","doi-asserted-by":"publisher","first-page":"313","DOI":"10.5009\/gnl.2014.8.3.313","article-title":"Gallstone disease does not predict liver histology in non-alcoholic fatty liver disease","volume":"8","author":"Yilmaz","year":"2014","journal-title":"Gut Liver."},{"key":"B10","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/ajg.2013.70","article-title":"Relationship of non-alcoholic fatty liver disease with cholecystectomy in the US population","volume":"108","author":"Ruhl","year":"2013","journal-title":"Am J Gastroenterol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/j.jhep.2019.08.019","article-title":"Transient elastography for screening of liver fibrosis: cost-effectiveness analysis from six prospective cohorts in Europe and Asia","volume":"71","author":"Serra-Burriel","year":"2019","journal-title":"J Hepatol."},{"key":"B12","first-page":"1","article-title":"National health and nutrition examination survey, 2015-2018: sample design and estimation procedures","volume":"2","author":"Chen","year":"2020","journal-title":"Vital Health Stat"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e296","DOI":"10.1371\/journal.pmed.0040296","article-title":"The Strengthening the reporting of observational studies in epidemiology (strobe) statement: guidelines for reporting observational studies","volume":"4","author":"von Elm","year":"2007","journal-title":"PLoS Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1002\/hep.29302","article-title":"Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with non-alcoholic fatty liver disease: a meta-analysis","volume":"66","author":"Xiao","year":"2017","journal-title":"Hepatology."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e021787","DOI":"10.1136\/bmjopen-2018-021787","article-title":"Diagnostic accuracy of point shear wave elastography and transient elastography for staging hepatic fibrosis in patients with non-alcoholic fatty liver disease: a meta-analysis","volume":"8","author":"Jiang","year":"2018","journal-title":"BMJ Open."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1002\/hep.28394","article-title":"Liver stiffness in non-alcoholic fatty liver disease: a comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy","volume":"63","author":"Cassinotto","year":"2016","journal-title":"Hepatology."},{"key":"B17","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2147\/NSS.S290465","article-title":"Circadian misalignment rather than sleep duration is associated with MAFLD: a population-based propensity score-matched study","volume":"13","author":"Weng","year":"2021","journal-title":"Nat Sci Sleep."},{"key":"B18","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.2337\/dc20-S002","article-title":"Classification and diagnosis of diabetes: standards of medical care in diabetes-2020","volume":"43","year":"2020","journal-title":"Diabetes Care"},{"key":"B19","first-page":"362","article-title":"Testing for HCV infection: an update of guidance for clinicians and laboratorians","volume":"62","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"B20","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1053\/j.gastro.2018.11.037","article-title":"New and old biomarkers for diagnosis and management of chronic hepatitis b virus infection","volume":"156","author":"Coffin","year":"2019","journal-title":"Gastroenterology."},{"key":"B21","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.aohep.2020.03.006","article-title":"Blood lead level is associated with advanced liver fibrosis in patients with non-alcoholic fatty liver disease: A nationwide survey (NHANES 2011-2016)","volume":"19","author":"Reja","year":"2020","journal-title":"Ann Hepatol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1001\/jama.2018.14854","article-title":"The physical activity guidelines for Americans","volume":"320","author":"Piercy","year":"2018","journal-title":"JAMA."},{"key":"B23","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/hep.30834","article-title":"The role of senescence in the development of non-alcoholic fatty liver disease and progression to non-alcoholic steatohepatitis","volume":"71","author":"Papatheodoridi","year":"2020","journal-title":"Hepatology."},{"key":"B24","doi-asserted-by":"publisher","first-page":"729","DOI":"10.21037\/atm-20-4354","article-title":"Non-alcoholic fatty liver disease (NAFLD)\/non-alcoholic steatohepatitis (NASH)-related liver fibrosis: mechanisms, treatment and prevention","volume":"9","author":"Tacke","year":"2021","journal-title":"Ann Transl Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"519","DOI":"10.2337\/dc20-1778","article-title":"Perseghin G. High prevalence of advanced liver fibrosis assessed by transient elastography among US adults with type 2 diabetes","volume":"44","author":"Ciardullo","year":"2021","journal-title":"Diabetes Care."},{"key":"B26","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1007\/s10620-017-4768-7","article-title":"Endoscopic therapy of biliary injury after cholecystectomy","volume":"63","author":"Rainio","year":"2018","journal-title":"Dig Dis Sci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"4294","DOI":"10.1007\/s00464-016-4745-9","article-title":"Long-term outcomes of patients with common bile duct injury following laparoscopic cholecystectomy","volume":"30","author":"Halbert","year":"2016","journal-title":"Surg Endosc."},{"key":"B28","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.jamcollsurg.2017.12.023","article-title":"Diminished survival in patients with bile leak and ductal injury: management strategy and outcomes","volume":"226","author":"Fong","year":"2018","journal-title":"J Am Coll Surg."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1007\/s00464-017-5847-8","article-title":"Bile duct injury and morbidity following cholecystectomy: a need for improvement","volume":"32","author":"Barrett","year":"2018","journal-title":"Surg Endosc."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.14309\/ajg.0000000000000704","article-title":"Management of postcholecystectomy biliary complications: a narrative review","volume":"115","author":"Ahmad","year":"2020","journal-title":"Am J Gastroenterol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1097\/SLA.0000000000003155","article-title":"What have we learned from malpractice claims involving the surgical management of benign biliary disease?: a 128 million dollar question","volume":"269","author":"Gartland","year":"2019","journal-title":"Ann Surg."},{"key":"B32","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.jviscsurg.2014.05.006","article-title":"Long-term consequences of bile duct injury after cholecystectomy","volume":"151","author":"Barbier","year":"2014","journal-title":"J Visc Surg."},{"key":"B33","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.mri.2020.08.016","article-title":"Influence of cholecystectomy on the flow dynamic pattern of bile in the extrahepatic bile duct: assessment by cine-dynamic MRCP with spatially-selective IR pulse","volume":"74","author":"Sotozono","year":"2020","journal-title":"Magn Reson Imaging."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e3140","DOI":"10.1002\/dmrr.3140","article-title":"Gall bladder: The metabolic orchestrator","volume":"35","author":"Qi","year":"2019","journal-title":"Diabetes Metab Res Rev."},{"key":"B35","doi-asserted-by":"publisher","first-page":"e88189","DOI":"10.1371\/journal.pone.0088189","article-title":"Association of cholecystectomy with metabolic syndrome in a Chinese population","volume":"9","author":"Shen","year":"2014","journal-title":"PLoS One."},{"key":"B36","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/labinvest.2017.95","article-title":"Cholecystectomy as a risk factor of metabolic syndrome: from epidemiologic clues to biochemical mechanisms","volume":"98","author":"Chen","year":"2018","journal-title":"Lab Invest."},{"key":"B37","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1183\/13993003.00601-2018","article-title":"Increased liver stiffness in patients with severe sleep apnoea and metabolic comorbidities","volume":"51","author":"Trzepizur","year":"2018","journal-title":"Eur Respir J."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1053\/j.gastro.2012.04.036","article-title":"cholecystohepatic shunt pathway: does the gallbladder protect the liver?","volume":"142","author":"Boyer","year":"2012","journal-title":"Gastroenterology."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1136\/gutjnl-2016-312975","article-title":"Fibroblast growth factor 15\/19 (FGF15\/19) protects from diet-induced hepatic steatosis: development of an FGF19-based chimeric molecule to promote fatty liver regeneration","volume":"66","author":"Alvarez-Sola","year":"2017","journal-title":"Gut."},{"key":"B40","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12967-016-0821-0","article-title":"Regulation of fibroblast growth factor 15\/19 and 21 on metabolism: in the fed or fasted state","volume":"14","author":"Guan","year":"2016","journal-title":"J Transl Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.semcdb.2015.09.021","article-title":"Metabolic fibroblast growth factors (FGFs): Mediators of energy homeostasis","volume":"53","author":"Markan","year":"2016","journal-title":"Semin Cell Dev Biol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/SLA.0000000000003791","article-title":"Safe Cholecystectomy Multi-society Practice Guideline and State of the Art Consensus Conference on Prevention of Bile Duct Injury During Cholecystectomy","volume":"272","author":"Brunt","year":"2020","journal-title":"Ann Surg."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1016\/S0140-6736(19)32478-X","article-title":"Time to revisit indications for cholecystectomy","volume":"394","author":"Moris","year":"2019","journal-title":"Lancet."},{"key":"B44","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.gie.2015.01.024","article-title":"Value of EGD in patients referred for cholecystectomy: a systematic review and meta-analysis","volume":"82","author":"Lamberts","year":"2015","journal-title":"Gastrointest Endosc."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.787777\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T16:55:54Z","timestamp":1638377754000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.787777\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,30]]},"references-count":44,"alternative-id":["10.3389\/fmed.2021.787777"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2021.787777","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,30]]},"article-number":"787777"}}